Literature DB >> 7901063

Struma ovarii.

A Ayhan1, F Yanik, R Tuncer, Z S Tuncer, S Ruacan.   

Abstract

OBJECTIVE: To review the clinicopathological experience of patients with benign and malignant struma ovarii.
METHOD: A retrospective institutional analysis of 2 patients with malignant and 14 patients with benign struma ovarii, treated during a period of 20 years. RESULT: The patients with struma ovarii constituted 1.0% of all ovarian neoplasms in our institution (16/1501). Four percent of the germ cell tumors were calculated to be of struma ovarii (16/382). The stages of the malignant cases were recorded as 1A and 1C. Besides detection at early stage, a biologically low grade tumor was encountered as well. Although 5 of the patients had goitre, none of them had hyperthyroidism. None of the patients had a bilateral tumor. However, in 2 patients, a serous cystadenoma and dermoid cyst were found in the contralateral ovaries. The preoperative and intraoperative diagnosis of malignant struma ovarii proved to be difficult since 2 patients subjected to radical surgery according to suspicious frozen section reports in this series later were found to be benign struma ovarii.
CONCLUSION: The low metastatic potential and slow progression rate of malignant struma ovarii support conservative surgery especially in young patients who have not yet completed their families.

Entities:  

Mesh:

Year:  1993        PMID: 7901063     DOI: 10.1016/0020-7292(93)90628-a

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  9 in total

1.  Struma ovarii: management and follow-up of a rare ovarian tumour.

Authors:  Jonathan Yeow Sherng Wee; Xinyi Li; Bernard Su Min Chern; Irene Sze Yuen Chua
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

Review 2.  Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.

Authors:  Erin F Wolff; Marybeth Hughes; Maria J Merino; James C Reynolds; Jeremy L Davis; Craig S Cochran; Francesco S Celi
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

3.  Malignant struma ovarii.

Authors:  Fevziye Kabukcuoglu; Alparslan Baksu; Banu Yilmaz; Alpay Aktumen; Ismail Evren
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

4.  A case of papillary thyroid carcinoma in struma ovarii and review of the literature.

Authors:  W D Salman; Mayuri Singh; Z Twaij
Journal:  Patholog Res Int       Date:  2010-08-02

5.  Radiotherapy with iodine-131 in recurrent malignant struma ovarii.

Authors:  W Brenner; K H Bohuslavizki; H Wolf; C Sippel; M Clausen; E Henze
Journal:  Eur J Nucl Med       Date:  1996-01

6.  Clinical characteristics of struma ovarii.

Authors:  Seung-Chul Yoo; Ki-Hong Chang; Mi-Ok Lyu; Suk-Joon Chang; Hee-Sug Ryu; Haeng-Soo Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

7.  Malignant struma ovarii: good response after thyroidectomy and I ablation therapy.

Authors:  Erica W M Janszen; Helena C van Doorn; Patricia C Ewing; Ronald R de Krijger; Johannes H W de Wilt; Boen L R Kam; Wouter W de Herder
Journal:  Clin Med Oncol       Date:  2008-02-29

8.  Struma Ovarii: A Report of Three Cases and Literature Review.

Authors:  Pratibha Singh; Nitisha Lath; Shashank Shekhar; Manu Goyal; Meenakshi Gothwal; Garima Yadav; Pushpinder Khera
Journal:  J Midlife Health       Date:  2018 Oct-Dec

9.  Huge follicular carcinoma originated from struma ovarii in young woman; Extremely rare case.

Authors:  Chul Min Park; Bo Ram Kim; Hye Sim Kang
Journal:  Ann Med Surg (Lond)       Date:  2021-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.